My clinical activities are focused on caring for patients with chronic kidney disease (CKD) and those with end-stage renal disease undergoing renal replacement therapy. I am the Chief Medical Officer of Erie County Medical Center (ECMC); as such, I am responsible for ensuring that the hospital has a high-quality, safe and efficient environment in which our health care professionals can render the best possible care for all patients. I also serve as the liaison between physicians and hospital administration, helping the latter to develop hospital policy and its strategic vision.
My research is focused on addressing population health management. With the use of bioinformatics, my goal is to develop methods that will permit earlier detection of kidney disease and improved models for delivering extended care management for patients with CKD. My past research has included study of the diagnosis and treatment of viral diseases in transplant patients, vascular access problems in hemodialysis patients and the early identification and treatment of CKD.
Education and Training:
Fellowship, Renal, University of Minnesota Hospitals (1985)
Residency, Internal Medicine, Trinity College, University of Dublin (1982)
Internship, Internal Medicine, Trinity College, University of Dublin, Meath Hospital (1980)
MD, Internal Medicine, Nephrology, Trinity College, University of Dublin, graduated with honors (1979)
Interim Director, Transplant and Renal Center of Excellence, Erie County Medical Center (2011-present)
Chief Medical Officer, Erie County Medical Center (2008-present)
Associate Professor of Medicine, Medicine, University at Buffalo (1994-present)
Attending Physician, Internal Medicine, Erie County Medical Center (1985-present)
Associate Medical Director, Erie County Medical Center (2004–2008)
Medical Director, Clevehill Dialysis Unit (1996–2004)
Medical Director, Hemodialysis Unit, Erie County Medical Center (1989–2004)
President, Medical/Dental Staff, Erie Country Medical Center (2000–2002)
Assistant Professor of Medicine, Medicine, University at Buffalo (1985–1994)
Acting Director, Hemodialysis Unit, Erie Country Medical Center (1988–1989)
Research Assistant Professor, Medicine, University at Buffalo (1986–1989)
Part-Time Staff Physician (Emergency Room), University of Minnesota Hospitals (1984–1985)
Best of the Best Award, Region‘s Highest Health Care Honor (2004)
Gift of Life Award, National Kidney Foundation of WNY (2004)
Fellowship of the Royal College of Physicians of Ireland (1995)
Fellowship of the American College of Physicians (1995)
Travel Fellowship to the X International Congress of Nephrology, London, England (1987)
Scientific Achievement Award (1984)
Sir James Craig Memorial Prize (1st Place) in Medicine, Trinity College in Dublin (1979)
Gold Medal and Moderatorship Prize (1st Place) in the Faculty of Natural Sciences, Trinity College in Dublin (1976)
Grants and Sponsored Research:
November 2006–February 2012 EVOLVE Trial: Evaluation of Cinacalcet HCI Therapy to Lower Cardiovasclar Events Amgen Inc. Role: Co-Investigator
July 2006–June 2008 The Use of Virtual Case Management to Improve Diagnosis and Treatment of Chronic Kidney Disease Agency for Healthcare Research and Quality Role: Co-Investigator
July 2005–June 2006 Quality Improvement Research to Improve Care of Chronic Kidney Disease in Patients Admitted for Cardiovascular Disease at ECMC National Kidney Foundation of WNY Role: Principal Investigator
September 2002–August 2005 Flow Measurement at Dialysis Access Salvage National Institutes of Health Role: Principal Investigator
February 2003–January 2004 Predicting Graft Thrombosis: Pressures and Flows? DaVita Research Grant Role: Principal Investigator
March 2002–March 2003 Phase III, Prospective, Randomized, Placebo-Controlled, Double-blind, Multi-Center Study to Determine the Safety and Efficacy of Zemplar Capsules in Reducing Elevated Serum Intact Parathyroid Hormone Levels in Subjects with Chronic Kidney Disease Abbott Laboratories Role: Co-Investigator
December 2001–June 2002 Treatment of Anemia in Chronic Renal Failure Amgen Inc. Role: Principal Investigator
April 2001–March 2002 Pilot Study of Measurements of Access Blood Flow During Radiological Angioplasty of Hemodialysis Arteriovenous Grafts Using a Specially-Designed Catheter WNY Kidney Foundation/UNYTS Role: Principal Investigator
Murray BM, M. Panesar, N. Shah, V. Shah, K. Ivaturiu, G. Gudleski, M. Muscarella, J. Lambert, W. Su.. Therapeutic Apheresis and Dialysis. Therapeutic Apheresis and Dialysis. 2015.
Murray BM. Long-term outcomes of pancreas after kidney transplantation in small centers. Is it justified?. Transplantation Proceedings. 2014.
Murray BM. Effect of steroid-freelow concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.. Nephrology Dialysis & Transplantation. 2012.
Murray BM, Amsterdam D, Gray V, Myers J, Gerbasi J, Venuto R. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.. J Am Soc Nephrol. 1997; 8(9).
Evans, M. J., Edwards-Spring, Y., Myers, J., Wendt, A., Provinelli, D., Daniel Amsterdam, Rittenhouse-Diakun, K., Armstrong, D., Murray, B. M., Greenberg, S. J., Riepenhoff-Talty, M.. Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipients. Immunological Investigation. 1997; 26(1&2).